ERIKA LEE FINANGER M.D.
Prescription History 1487709259
Psychiatry & Neurology - Neurology with Special Qualifications in Child Neurology in Portland, OR

Active since January 24, 2007PECOS Enrolled
97.83/100
CMS Quality Rating
3181 SW SAM JACKSON PARK RD, CDRC-P, PORTLAND, OR 97239(503) 494-2370 Get Directions

NPPES record last updated: October 27, 2011. Verified against the NPPES registry weekly; last sync: October 18, 2026.

Medicare Part D Prescription History

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for ERIKA LEE FINANGER M.D., an active Neurology with Special Qualifications in Child Neurology specialist practicing in Portland, OR. Our medical registry currently tracks 2 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 31 documented patient claims. Among these therapy options, the most frequently utilized medication is Exondys-51, which accounts for 18 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.

2
Medications
31
Total Claims
31
30-Day Fills
Exondys-51
Most Prescribed · 18 claims
View details
2 medications · 2024 Medicare Part D
Medicare Part D medications prescribed by ERIKA LEE FINANGER M.D. in 2024, with prescription volumes, average cost per fill, and OR state comparisons
Medication Prescriptions (2024)Rx (2024) Avg Cost per FillCost / Fill Vs. Other OR PrescribersVs. OR Avg
Exondys-51Eteplirsen18$89,940.48– No State Data

About Exondys-51: Eteplirsen is used to treat a certain inherited muscle disorder (Duchenne muscular dystrophy-DMD). Show more ▾

This disorder is caused by a lack of a certain muscle protein (dystrophin). This medication can increase the amount of dystrophin in your body. A phosphorodiamidate morpholino oligomer used in the treatment of DUCHENNE MUSCULAR DYSTROPHY with genetic mutations amenable to skipping exon 51.

In 2024, this provider wrote 18 Medicare prescriptions for Exondys-51. Medicare paid an average of $89,940.48 per fill. No state comparison is available for this medication.

How often this provider prescribes it

No state benchmark is available for this medication.

What Medicare paid per fill

$89,940.48
Cost per fill

Gross Part D cost per fill; not the patient's out-of-pocket price.

18
30-Day Fills
standardized to 30-day supplies
504
Days of Medication
total across all patients in 2024
EmflazaDeflazacort13$11,858.96– No State Data

About Emflaza: This medication is used to treat a certain inherited muscle disorder (Duchenne muscular dystrophy-DMD). Show more ▾

Deflazacort belongs to a class of drugs known as corticosteroids.

In 2024, this provider wrote 13 Medicare prescriptions for Emflaza. Medicare paid an average of $11,858.96 per fill. No state comparison is available for this medication.

How often this provider prescribes it

No state benchmark is available for this medication.

What Medicare paid per fill

$11,858.96
Cost per fill

Gross Part D cost per fill; not the patient's out-of-pocket price.

13
30-Day Fills
standardized to 30-day supplies
366
Days of Medication
total across all patients in 2024
No medications match the current filters.
▲ More than typical≈ Typical▼ Less than typical= prescription volume vs the average OR prescriber of the same medication; volume reflects practice size as well as clinical preference.Green cost= below the OR average cost per fill.

About this data. The prescription history for ERIKA LEE FINANGER M.D. is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Neurology with Special Qualifications in Child Neurology prescribing approach at this Portland, OR practice.

Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among OR prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.

About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.